Merz Therapeutics to Acquire Two Drugs from Acorda Therapeutics in $185 Million Deal

Merz Therapeutics to Acquire Two Drugs from Acorda Therapeutics in $185 Million Deal

Merz Therapeutics GmbH, a subsidiary of the Merz Group (Frankfurt/Main), signed an agreement to acquire two marketed drugs from the NASDAQ-listed US company Acorda Therapeutics. The completion of the transaction will “significantly contribute to Merz Therapeutics’ accelerated growth strategy,” the company said. It is the second investment in a NASDAQ company in just over ten … Read more

Biotech Company with Huge Potential: Two Approved Projects and Five More in Development

Biotech Company with Huge Potential: Two Approved Projects and Five More in Development

Two projects already approved and five more in development – ​​with these impressive numbers and a potential market of 183 million patients, the hot stock of the week presents itself as a company with enormous potential. The need for effective therapies to treat diseases of the central nervous system is enormous and constantly increasing. Diseases … Read more

Researchers in Brazil grew microalgae to extract lipids and other metabolites for biofuel and cosmetic production. Stress increased lipid production by 49%.

Microalgae has emerged as a promising source of renewable energy in recent years. These microscopic photosynthetic organisms have the potential to produce clean and sustainable fuel that can reduce our dependency on fossil fuels. Researchers around the world are exploring various methods for cultivating microalgae and extracting their lipid content for biofuel production. This article … Read more

BioNTech/Pfizer vaccines for thousands of Germans in China

AFP extension ANNOUNCEMENTS•yesterday, 18:34 Germans living in China can travel to embassies and consulates in the coming weeks for the BioNTech/Pfizer corona vaccine. A first load of doses is already on its way to Beijing, according to the German government. Previously, the Chinese authorities had already given their green light for the vaccinations. The BioNTech/Pfizer … Read more

Coronavirus vaccination: fourth most decisive dose of the omicron adjustment

Researchers are fiercely discussing what led to the adaptation of corona vaccines to the BA.5 variant. While vaccine makers Biontech and Moderna are touting the benefits of the new bivalent booster vaccines, a new independent laboratory study by researchers in Göttingen and Hanover now suggests that while there is an additional benefit from the upgrade, … Read more

Corona: RKI reports the numbers ++ Which diseases are now increasing

News blog Corona numbers are no longer declining – more respiratory diseases 02.12.2022, 07:16 | Reading time: 3 minutes Isolation obligation for coronavirus positives lifted in four federal states Isolation obligation for coronavirus positives lifted in four federal states Transition phase from pandemic to endemic: this is the reason given by four federal states that … Read more

Road to the cancer vaccine

Using the mRNA technology that has stopped covid, progress is being made in studies to treat some types of cancer Several vaccines against the SARS-CoV-2 virus have emerged from the pandemic. Professors Ugur Sahin and Ozlem Tureci are behind the most successful vaccines against the virus responsible for the pandemic. In 2008, they co-founded the … Read more

Ose Immunotherapeutics has an international scientific council – Le Journal des Entreprises – Loire-Atlantique

The Nantes biotechnology company Ose Immunotherapeutics creates an international scientific council. Composed of Pr. Wolf-Hervé Fridman (University of Paris), Dr. Sophie Brouard (CRTI, Nantes), Dr. Bernard Malissen (CIML, Marseille), Pr. Miriam Merad (Mount Sinaï, New York), Pr. Charles Serhan ( Harvard, Boston) and Dr. Jennifer Wargo (MT Anderson Cancer Center, Houston), he will work in … Read more

Tomorrow’s biontech: venture capitalists reveal Germany’s biotech hopes

Frankfurt The success of the Covid-19 vaccine developer Biontech has brought new attention to German biotech companies. However, regardless of the success of Biontech, the industry has again moved more into the focus of venture capitalists, even if financing and production are still more difficult in Germany than in the USA. The cancer specialist is … Read more

Nantes-based biotech Xenothera announces the efficacy of its treatment against Sars-Cov-2 variants – Le Journal des Entreprises – Loire-Atlantique

While Valneva has just announced that the British government has ordered 40 million doses of its candidate vaccine against Covid-19 for 2022, another Nantes biotech is in the spotlight. Xenothera let know, Monday 1is February, that Xav-19, its anti-Covid-19 treatment, has a blocking effect “against the various variants currently circulating, known as British, South African, … Read more